Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Ladoire

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
Oncoimmunology|July 30, 2016
Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrateSylvain Ladoire, Laura Senovilla, David Enot, et al.
Cell Reports|April 27, 2017
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 DeacetylationEmeric Limagne, Marion Thibaudin, Romain Euvrard, et al.
Cancers|February 25, 2023
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast CancerLoïck Galland, Nicolas Roussot, Isabelle Desmoulins, et al.
Pharmaceutics|October 23, 2021
Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated PatientsAlexandre Le Marouille, Emma Petit, Courèche Kaderbhaï, et al.
Pharmacogenomics|August 31, 2022
Detection of relevant pharmacogenetic information through exome sequencing in oncologySimon Verdez, Juliette Albuisson, Yannis Duffourd, et al.
Cancers|November 13, 2021
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, et al.
NPJ Breast Cancer|February 1, 2025
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclibSylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.
Nature Communications|December 14, 2017
IRF8-dependent molecular complexes control the Th9 transcriptional programEtienne Humblin, Marion Thibaudin, Fanny Chalmin, et al.
The Journal of Pathology|March 26, 2011
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survivalSylvain Ladoire, Grégoire Mignot, Sandrine Dabakuyo, et al.
The Oncologist|January 8, 2011
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agentsSylvain Ladoire, Franck Bonnetain, Mélanie Gauthier, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Oncoimmunology|July 30, 2016
Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrateSylvain Ladoire, Laura Senovilla, David Enot, et al.
Cell Reports|April 27, 2017
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 DeacetylationEmeric Limagne, Marion Thibaudin, Romain Euvrard, et al.
Cancers|February 25, 2023
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast CancerLoïck Galland, Nicolas Roussot, Isabelle Desmoulins, et al.
Pharmaceutics|October 23, 2021
Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated PatientsAlexandre Le Marouille, Emma Petit, Courèche Kaderbhaï, et al.
Pharmacogenomics|August 31, 2022
Detection of relevant pharmacogenetic information through exome sequencing in oncologySimon Verdez, Juliette Albuisson, Yannis Duffourd, et al.
Cancers|November 13, 2021
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, et al.
NPJ Breast Cancer|February 1, 2025
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclibSylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.
Nature Communications|December 14, 2017
IRF8-dependent molecular complexes control the Th9 transcriptional programEtienne Humblin, Marion Thibaudin, Fanny Chalmin, et al.
The Journal of Pathology|March 26, 2011
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survivalSylvain Ladoire, Grégoire Mignot, Sandrine Dabakuyo, et al.
The Oncologist|January 8, 2011
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agentsSylvain Ladoire, Franck Bonnetain, Mélanie Gauthier, et al.
Pageof 17